Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Dosage of Acetazolamide for Obstructive Sleep Apnea Treatment: a Parallel-group, Double-blind, Placebo-controlled, Randomized Trial

NCT04726982 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT04726982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04726982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Dosage of Acetazolamide for Obstructive Sleep Apnea Treatment: a Parallel-group, Double-blind, Placebo-controlled, Randomized Trial
Lead sponsor
University Hospital, Antwerp
Phase
Phase 4
Overall status
Completed
Start date
April 20, 2021
Completion date
May 5, 2024
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea